Close co-operation on research activities exists with many departments
Within the hospital close co-operation on research activities exists with many departments:
Department of Tumor Biology.
Department of Tumor Biology.
- By DNA microarray gene expression and chromosome structure are studied. The research focus on discovering new classifications, to predict chemotherapy effect and resistance mechanisms.
- Studies of liposarcomas by spesific ligands for PPAR-gamma in xenographt.
- Microscopic disease in ostosarcoma: Immunomagnetic isolation of tumor cells present in peripheral blood and bone marrow aspirates in osteosarcoma patients, useful as diagnostic and prognostic tool in the management of osteosarcoma.
- Cytogenetic analyses serves as a diagnostic marker for many subtypes of sarcoma and translocation studies are ongoing.
- Analyses of the influence of SNP`s on response and toxic effect of cytostatic drugs.
- Ex vivo expansion of hematopoietic progenitor cells to alleviate thrombocytopenia following high-dose chemotherapy for higly malignant sarcoma of bone.
- Targeted internal radionuclide treatment employing 153-Samarium-EDTMP for advanced bone sarcoma (clinical phase II study)
- Studies of pharmacokinetics and markers indicating toxic effect of cytostatic drugs in osteosarcoma patients.
- Evaluation of response by MRI in Ewing sarcoma.
- Studies of pathology, radiology and clinical history in patients with radiation induced sarcoma
- Formal co-operation has been established in order to increase the knowledge of the effect of rehabilitation on patients with serious function defects.
- The expression of retinoid binding proteins in sarcomas.
- Quality of life and long term morbidity among survivors after multimodal treatment for Ewing`s sarcoma and osteosarcoma
- A study of prognostic factors in osteosarcoma
- Genetic factors determining chemosensitivity and –resistance in bone and soft tissue sarcoma.




Go back
Print this page
E-mail this page
